Organon determines optimum way to fulfill demand with Infor SCM
Organon produces prescription medicines from raw material (or “active material”). The company’s core business is developing the products and addressing specific local market needs. However, each country has its own constraints. For example, French regulatory affairs require that the information included on and in the package is written in French, while in other countries like Sweden, Norway, or Denmark, other languages are required. Another geographical difference is branding. It’s possible that the same drug has a different name per country because of cultural influences or simply because the name has a different meaning in the native language.
Please register below for immediate access to this report.